Novo Nordisk’s amycretin drug helps obese adults lose 24% weight
HQ Team June 21, 2025: Novo Nordisk’s experimental weight loss medicine amycretin helped overweight and obese adults lose up to 24% of their.
Drugs
Health
Pharma